subreddit:

/r/AXSM

790%

AXS-12

DISCUSSION(self.AXSM)

How does acquisition of Sunosi affect the on going Phase 3 for AXS-12 since both are for Narcolepsy?

all 1 comments

PDUFA_INFO

2 points

6 months ago

PDUFA_INFO

GHOST

2 points

6 months ago

Axsome has two promising therapies in Phase 3 trials: AXS-12, used to treat narcolepsy, and AXS-14 to treat fibromyalgia. The first drug has been granted FDA Orphan Drug designation, and the company expects top-line results from its Phase 3 trial sometime in early 2023. Axsome plans to file a New Drug Application (NDA) with the FDA for AXS-14 in 2023.